A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples